Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial
Maselli, Daniel, Atieh, Jessica, Clark, Matthew M., Eckert, Deborah, Taylor, Ann, Carlson, Paula, Burton, Duane D., Busciglio, Irene +4 more·2022·Obesity
Cited by (136)
Items 101–136 of 136
- Liraglutide - A Promising Approach Against ObesityNabila Rafi, Muhammad Sajid Abbas Jaffri, Kamran Yousuf · 2025 · Journal of Bahria University Medical and Dental College
- Controversies on the effects of GLP-1 receptor agonist treatment on gastric emptyingMiguel Ángel Rubio, Irene Bretón Lesmes · 2025 · Endocrinología Diabetes y Nutrición (English ed )
- GLP-1 receptor agonist safety in a perioperative setting: more questions than answersGraziella Aquilina, Sarah Valerie Casha, Maria Cordina, Ivan Debono, Anthony George Fenech, Janet Mifsud, Vanessa Petroni Magri, Cesca Vassallo, Janet Sultana · 2026 · Expert Review of Clinical Pharmacology
- 22 還元進行過程の調査 : 小型高炉による製銑過程に関する基礎研究 I(製銑, 日本鉄鋼協会第 70 回(秋季)講演大会講演論文集 (I))明光 大蔵, F. P. カルデロン, 幸雄 松下 · 1965 · 鐵と鋼 : 日本鐡鋼協會々誌
- Evaluation of the Effectiveness of Liraglutide on Metabolic Parameters in the Treatment of ObesityAyşen Akkurt · 2023 · Cureus
- Patología motora y trastornos del vaciamiento gástricoI. Enciso, Y. Soto, M. Martín-Arranz · 2024 · Medicine - Programa de Formación Médica Continuada Acreditado
- The Impact of Blood Glucose and Antidiabetic Medications on Osteoarthritis: A Mendelian Randomization StudyJunjie Wang, Yuxuan Li, Binyang Wang, Qing Ma, Lvlin Yang · 2024 · Research Square
- Obesidad y riesgo cardiovascular: liraglutida y sus beneficios terapéuticosWashington Moises Moreira Mendoza, Luis Enrique Bravo Vaca, Mayker Armando Carbo Bazurto, Eimy Marcela Del Valle Velez, Marjorie Briggitte Mendoza Pin, Jhon Alexander Ponce Alencastro · 2024 · AlfaPublicaciones
- Current Approach of Diabetes Mellitus in Obese PatientsSülbiye Karaburgu · 2023
- Super response to liraglutide in people with obesity: A case report and literature reviewSonsoles Gutiérrez Medina, Elena Sánchez Campayo, Sonsoles Guadalix, Javier Escalada · 2024 · Endocrinología Diabetes y Nutrición (English ed )
- A Precision Medicine Approach for Obesity ManagementDiego Añazco, Fauzi Feris, Sima Fansa, Maria Antonia Espinosa, Andres Acosta · 2024 · Springer eBooks
- Controversias de los efectos del tratamiento con agonistas del receptor de GLP-1 sobre el vaciamiento gástricoMiguel Ángel Rubio, Irene Bretón Lesmes · 2024 · Endocrinología Diabetes y Nutrición
- Can the incidence of voluntarily reported side effects support the argument for a clinically relevant GLP-1RA tachyphylaxis? Comment on Br J Anaesth 2025; 134:1486–1496Ion A. Hobai · 2025 · British Journal of Anaesthesia
- Exploring the off-label use of liraglutide in the treatment of obesity: a reviewCarla Bruna Amorim Braga, João Paulo Viana Araújo Segundo, Carlos Alberto Alves Dias Filho · 2026 · Molecular and Cellular Biochemistry
- Esophageal high-resolution manometry can be safely and effectively performed with concurrent glucagon-like peptide-1 receptor agonist useKhushboo S. Gala, Preeyati Chopra, Ashwariya Ohri, Mayank Goyal, George W. Marek, Michael Camilleri, Karthik Ravi · 2025 · Diseases of the Esophagus
- A consensus statement from the European Society for Clinical InvestigationCarbone, Federico, Jean‐Pierre Després, John P. A. Ioannidis, Neeland, Ian J., Garruti, Gabriella, Busetto, Luca, Liberale, Luca, Ministrini, Stefano, Gemma Vilahur, Schindler, Thomas H. et al. · 2025 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
- Impact of Obesity Medications on Gastric FunctionJ. Alexander Torres, Shelby A. Sullivan · 2026 · Foregut The Journal of the American Foregut Society
- GLP-1 receptor agonists and surgical care: implications for bariatric Procedures, perioperative Outcomes, and nutritional optimizationZeyad Elawa, Ahmed Khalil, Ahmed Kardousha, Ahmed Elawwa, Ashraf Tawfik Soliman · 2026 · Diabetes Research and Clinical Practice
- The perioperative implications of GLP-1 receptor agonists: a narrative reviewPaul Anthony Stewart, Claire C. Nestor, Cillian Clancy, Michael G. Irwin · 2026 · Anaesthesia & intensive care medicine
- GLP-1 therapies for obesity: mechanisms, outcomes, and regulatory challengesDebora de Oliveira Emos, José de Jesús Martínez González, Luísa Maria Diani, Marcela Augusta de Souza Pinhel, Lígia Moriguchi Watanabe, Ana Vitória Leca, Camila Fernanda Cunha Brandao, Carla Barbosa Nonino, Natália Yumi Noronha · 2026 · Academia Drug Development and Pharmacotherapy
- Body Composition Optimization in the Era of GLP‐1‐Based Pharmacotherapy for Obesity ManagementGrant M. Tinsley, Spencer Nadolsky, Karl Nadolsky · 2026 · Lifestyle Medicine
- Altered eating experience during GLP-1 receptor agonist therapy: a sensory–liking–wanting framework for food preference and nutritional behaviourJiayi Du, Zhuo Yang, Yan Chen · 2026 · Frontiers in Nutrition
- Therapeutic Potential of Anti-Obesity Drugs in Obesity-Associated Female Reproductive Dysfunction: Translating Mechanistic Evidence into Personalized Clinical StrategiesFani‐Niki Varra, Panagiotis Theodosis‐Nobelos, Viktoria‐Konstantina Varra, Michail N. Varras · 2026 · Medicina
- Molecular and cellular mechanisms of GLP-1 receptor agonists and their emerging clinical applicationsMateusz Kurowski, Katarzyna Rekiel, Aleksandra Marcinkowska, Oskar Ratajczyk, Piotr Urbanowicz, Stanisław Iwankiewicz, Wojciech Grzelczak, Zuzanna Kaz mierczak · 2026 · Medical Journal of Cell Biology
- Does the Carbohydrate-Insulin Model Explain Obesity? Evidence from Mechanistic and Clinical Studies: A Critical ReviewDamoon Ashtary‐Larky · 2026 · Current Obesity Reports
- GLP ‐1 Receptor Agonists, Gastric Emptying, and Mechanisms of Weight LossDavid S. Ludwig, Arne Astrup · 2026 · Obesity
- Response to “ GLP ‐1 Receptor Agonists, Gastric Emptying, and Mechanisms of Weight Loss”Mark I. Friedman, W. Scott Harmsen, Michael Camilleri · 2026 · Obesity
- Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes: An Updated Systematic ReviewMoiz, Areesha, Filion, Kristian B., Samuels, Aaron E., Tsoukas, Michael A., Yu, Oriana H.Y., Peters, Tricia M., Eisenberg, Mark J. · 2026 · Annals of Internal Medicine
- Genetic Variants Associated with Response to GLP-1 Receptor Agonists in Diabetes and ObesityMónica Teotónio Fernandes, Joana C. Dias, Margarida Espírito‐Santo, M. Dulce Estêvão, Ana Luísa De Sousa‐Coelho · 2026 · Life
- Weight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysisHuaji Qi, Qiang Gao, Haiyan Chen, Xiaodan Du, Bobo Pan · 2026 · PeerJ
- Exposure-driven tolerance modeling of efpeglenatide-induced nausea or vomiting using repeated time-to-event analysis: implications for dose-escalation strategiesJiyoung Seo, SeungChan Choi, NaYoung Kim, Hyeeun Kim, Hyeong-Seok Lim · 2026 · Frontiers in Pharmacology
- Why do some patients thrive on GLP-1 therapy while others do not? An ayurvedic perspective on metabolic heterogeneityUma Purighalla · 2026 · EXPLORE
- Genetic Polymorphisms in Obesity: Molecular Mechanisms, Clinical Implications and Precision Medicine ApproachesDemin Cao, Zhiwen Zhao · 2026 · IntechOpen eBooks
- Insights from multi-omics on GLP-1 receptor agonists in type 2 diabetes and obesityAsma A. Elashi, Laila Hedaya, Viviana Maggio, Khaled Naja, Manfredi Rizzo, Mohamed A. Elrayess · 2026 · Frontiers in Pharmacology
- Research Advances in Perioperative Gastrointestinal Ultrasonography Assessment and Aspiration Risk Management in Patients Receiving GLP-1 Receptor Agonists梦琪 焦 · 2026 · Advances in Clinical Medicine
- Influence of GLP‐1‐Based Pharmacotherapies on Eating Behavior, Appetite, and Energy Intake in Adults With Overweight or Obesity: A Systematic Review and Meta‐AnalysisClarissa A. Dakin, Jordan D. Beaumont, Beverley O’Hara · 2026 · Obesity Reviews